IRCT2014080818733N1已完成2 期
Intravitreal Bevacizumab alone or in combination with 1 mg Triamcinolone in diabetic macular edema
vice-chancellor for research-Tehran University of Medical Science0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 85 years（—）
- 性别
- All
入选标准
- •bilateral macular edema with foveal involvement; Visual acuity between 20/40-20/400; Age more than 20; HbA1c more less than 10; Blood pressure less than 160/100.
- •Exclusion criteria: previous panretinal or focal laser photocoagulation; prior vitreoretinalr surgery or injection; unilateral cataract surgery; history of glaucoma or ocular hypertension; VA worse than 20/400; proliferative diabetic retinopathy; significant media opacity; Monocularity; Central macular thickness>320; pregnancy; serum creatinine>3 mg/dl; other retinal diseases; unilateral cataract surgery; Cataract surgery during last 3 months; macular ischemia (Foveal avascular zone>100); uncontrolled blood pressure or diabetes with medication; previous corticostroid consumption during last 3 months; HbA1c>10
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Intravitreal bevacizumab injection versus subtreshold grid laser treatment for recurrent macular edema secondary to branch retinal vein occlusioRecurrent macular edema secondary to branch retinal vein occlusionJPRN-UMIN000005014Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele22
已完成
不适用
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
Unknown
3 期
Intravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDNeovascular Age-Related Macular DegenerationNCT00370370Shahid Beheshti University of Medical Sciences
尚未招募
不适用
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurityJPRN-UMIN000007465Tokushima university hospital10
已完成
1 期
Intravitreal Bevacizumab and Low Fluence Photodynamic TherapyMyopiaNCT00802126University of Campania "Luigi Vanvitelli"16